Monday, October 3, 2022
News
NEWS HOME
»
PRN INDIA
Frost & Sullivan Institute Recognizes Samsung Biologics with the 2022 Global Enlightened Growth Leadership Award for its Commitment to Sustainable Growth
  SocialTwist Tell-a-Friend  
   

Samsung Biologics' mission to create a better world through high-quality biopharmaceuticals is underscored by a series of global initiatives to deliver progress related to climate change

SAN ANTONIO, Aug. 9, 2022 /PRNewswire/ -- Frost & Sullivan Institute is proud to present Samsung Biologics with the 2022 Enlightened Growth Leadership Award. The Institute believes that all organizations must either create or become part of a solution that addresses threats to humanity. Samsung Biologics has not only demonstrated growth excellence through its strong financial performance in 2021, but also excels as a socially responsible enterprise with a concerted focus on the company's strong ESG and sustainability initiatives.

 Research from the Frost & Sullivan Institute and Frost & Sullivan, states that “With end-to-end, integrated biopharmaceutical solutions in contract development and manufacturing, and expansion plans across Asia, America, and Europe with an underlying vision to enrich human lives, Samsung Biologics stands out for its contribution in protecting and prolonging human lives by producing life-saving drugs and vaccines in collaboration with its clients."

As a response to climate change, Samsung Biologics made progress in reducing Scope 1 and 2 emissions by 32.3% compared to the previous year. To foster collaborative solutions, Samsung Biologics also announced its participation in the Frontier 1.5D initiative to develop a climate risk management model as part of the 2050 Carbon Neutral Strategy in response to the ongoing challenges associated with global climate change. The company is participating in the Health Systems Taskforce as part of His Royal Highness The Prince of Wales' Sustainable Markets Initiative, alongside global leaders from across the healthcare system, academia, and international organizations like the WHO and UNICEF. By committing to Science-Based Targets and environmental reporting in line with the Carbon Disclosure Project (CDP) and the Global Reporting Initiative (GRI), the company continues to effectively contribute to Sustainable Development Goals of Good Health and Well-Being and Responsible Consumption and Production.

Samsung Biologics has also been actively making social contributions, providing youth education and scholarship support, equitable access to quality and affordable healthcare services, and childcare support. Jointly with other Samsung affiliates, the company has introduced new programs like Dream Class to provide career counseling for students in low-income families and the Stepping Stone of Hope to offer training and support for at-risk youth.

Research from the Frost & Sullivan Institute and Frost & Sullivan, states that "With end-to-end, integrated biopharmaceutical solutions in contract development and manufacturing, and expansion plans across Asia, America, and Europe with an underlying vision to enrich human lives, Samsung Biologics stands out for its contribution in protecting and prolonging human lives by producing life-saving drugs and vaccines in collaboration with its clients. This recognition is also a testimony to Samsung Biologics' unwavering commitment to the vision of 'innovating to zero' – zero global illnesses, zero emissions, and zero workplace accidents achieved through professional excellence, science-based emission reduction targets, and robust safety assessment frameworks."

"We are proud to receive this award and be recognized for our efforts in proactively addressing global priorities, while securing continuous growth as a sustainable CDMO partner. We will continue to implement innovative and sound business practices throughout our value chains to build a healthier ecosystem, driving a sustainable future for all," said  John Rim, CEO and President of Samsung Biologics.

Frost & Sullivan Institute evaluates nominees on key best practices criteria such as Innovating to Zero, Growth Excellence, and so on. Samsung Biologics excels in multiple criteria.   The Enlightened Growth Leadership Awards recognize organizations that are committed to making the world a better place and that are part of the solution to challenges our world faces today. The Award considers the synergy between growth, CSR, and ESG. Recipient companies proactively utilize business practices to 'innovate to zero' and address global priorities while securing sustainable growth.  

Samsung Biologics, along with other recipients of the Enlightened Growth Leadership Best Practices Recognition, will be awarded and celebrated at our virtual banquet on 22nd November 2022.

About Frost & Sullivan Institute

The Frost & Sullivan Institute (FSI) is a non-profit organization dedicated to utilizing business practices to address global priorities. The genesis of the institute goes back to the vision of either creating, or becoming part of, a solution that addresses threats to humanity. The Institute has identified strategic imperatives for transformation and believes that we can truly accelerate innovation to zero. To learn more about FSI, visit www.frostandsullivaninstitute.org

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders, and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models, and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.

Media Contact:

Prerna Mohan
prerna.mohan@frost.com

About Samsung Biologics Co., Ltd.

Samsung Biologics (KRX: 207940.KS) is a fully integrated CDMO offering state-of-the-art contract development and manufacturing services. With proven regulatory approvals, the largest capacity, and the fastest throughput, Samsung Biologics is an award-winning partner of choice and is uniquely able to support the development and manufacturing of biologics products at every stage of the process while meeting the evolving needs of biopharmaceutical companies worldwide. For more information, visit samsungbiologics.com.

Samsung Biologics Contact:
Claire Kim
Senior Director of Global Marketing Communications
cair.kim@samsung.com

Photo - https://mma.prnewswire.com/media/1874915/EGL_Web_banner_Samsung_Biologics.jpg  

More News by PR Newswire India

FANDOM ACQUIRES LEADING ENTERTAINMENT & GAMING BRANDS INCLUDING GAMESPOT, TV GUIDE AND METACRITIC

National Engineering Industries Ltd (NBC Bearings) honored with 'Iconic Brands of India 2022'

Celebrating Glorious 35 Years of BIMTECH

HABANOS, S.A. PRESENTED THE MONTECRISTO WIDE EDMUNDO IN WORLD PREMIERE IN SPAIN

Sanjay Ghodawat Foundation awarded The Mahatma Award 2022

STL announces Gram Galaxy - India's first integrated solution to connect villages with fibre

DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY

Healthium Medtech amongst the first in Asia and first Indian Medtech Company to receive CE certification under the EU MDR (European Union Medical Device Regulation) norms for Class III implants

Jagadguru Kripalu Parishat holds Grand Rath Yatra on 3rd October 2022 near Kunda, Pratapgarh in honor of the 100th Birth Anniversary of Jagadguru Shri Kripalu Ji Maharaj

Addteq APAC Announces Rebranding, Changes Name to Enreap

Karwa Chauth 2022: FlowerAura Is All Geared Up To Enhance The Celebrations

DMCC AWARDED GLOBAL FREE ZONE OF THE YEAR FOR EIGHTH CONSECUTIVE YEAR

New Book Property Tax in Asia Provides the First Comprehensive Analysis of the Property Tax Across the World's Largest Continent

UN WOMEN'S HeForShe EXPANDS MOVEMENT THROUGH KEY PUBLIC AND PRIVATE PARTNERSHIPS IN EAST ASIA

STL unveils 5G cosmos to help Indian telcos fiberise their networks for 5G

STL launches Multiverse - India's first Multicore fibre and cable; aims to revolutionize the optical landscape

Tejas Networks successfully demonstrates end-to-end network based on its indigenous 4G/5G wireless, optical and satellite products

IIIT Hyderabad and Silicon Labs Launch Campus-wide Wi-SUN Network for Smart City Applications

STL unveils 5G cosmos to help Indian telcos fiberise their networks for 5G

STL launches Multiverse - India's first Multicore fibre and cable; aims to revolutionize the optical landscape

Tejas Networks successfully demonstrates end-to-end network based on its indigenous 4G/5G wireless, optical and satellite products

IIIT Hyderabad and Silicon Labs Launch Campus-wide Wi-SUN Network for Smart City Applications

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Mumbai Congress leader, 'Mummy' of Colab...
Durga Puja pandal fire in Uttar Pradesh'...
7-yr-old dies after electric scooter's b...
3 dead in Durga Puja pandal fire in UP's...
Navratri 2022: Maha Ashtami today, devot...
Made-In-India Light Combat Helicopter to...
More...    
 
 Top Stories
Nadda inspects arrangements for PM ... 
Shashi Tharoor highlights need for ... 
83 per cent of women have visited a... 
"No need to define 'Prachand', mess... 
Taiwan disapproves of China's false... 
World Team TT Championships: Indian... 
Mumbai: Man dies after chest pain w... 
Barmer girl rape: Accused arrested ...